Hair Relaxer Lawsuit

Uterine cancer, or endometrial cancer, is on the rise. So much so that experts expect the disease to become the third most common cancer among women by 2040. Additionally, the disease is likely to become the fourth leading cause of women’s cancer deaths.  There is strong scientific evidence driving our attorneys’ involvement in uterine cancer relaxer lawsuits.

Cancer of the uterus is the fourth most common type of cancer in women. According to the American Cancer Society, in 2022, there are: 

• About 65,950 new uterine cancer cases will be diagnosed.
• About 12,550 women will die from the disease.

The above cases include both endometrial and uterine sarcoma cancer.

Black women use hair straightening products more than any other demographic. Alarmingly, as uterine cancer rates and death rise in the U.S., those most likely to die from the disease are non-Hispanic Black women. Approximately 3.1% of all women will be diagnosed with uterine cancer in their lifetime. Black women, however, are significantly more likely than other racial groups to have advanced stages of uterine cancer when diagnosed. Further, they tend to have more aggressive tumor types, such as the following: 

• Clear cell
• Serous
• High-grade endometrioid 
• Malignant mixed Mullerian tumors
• Bleeding after menopause

In addition, research indicates that a cancer diagnosis in Black women has a greater mortality rate. The group is also less likely to receive the proper medical care for the disease than white women. This lack of quality healthcare greatly contributes to the racial disparities in mortality.  

Our staff has helped thousands of women file cancer lawsuits if their diagnosis resulted from a product. Our hair relaxer lawsuit lawyers have the skill to ensure you get the maximum compensation you deserve.